ECSP961661A - TRANSDERMAL FORMULACLION - Google Patents
TRANSDERMAL FORMULACLIONInfo
- Publication number
- ECSP961661A ECSP961661A ECSP961661A ECSP961661A EC SP961661 A ECSP961661 A EC SP961661A EC SP961661 A ECSP961661 A EC SP961661A EC SP961661 A ECSP961661 A EC SP961661A
- Authority
- EC
- Ecuador
- Prior art keywords
- transdermal
- formulaclion
- butylthio
- thiadiazol
- azabicyclo
- Prior art date
Links
- 238000009472 formulation Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- WZZPXVURFDJHGI-UHFFFAOYSA-N vedaclidine Chemical compound CCCCSC1=NSN=C1C1C(CC2)CCN2C1 WZZPXVURFDJHGI-UHFFFAOYSA-N 0.000 abstract 2
- 102000014415 Muscarinic acetylcholine receptor Human genes 0.000 abstract 1
- 108050003473 Muscarinic acetylcholine receptor Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
El invento se refiere al suministro de un método para tratar un acondición asociada con la modulación del receptor muscarínico usando una formulación transdémica de 3-[4-(butiltio)-1,2,5-tiadiazol-3-il] -azabiciclo-[2.2.2] octano. La invención suministra formulaciones transdérmicas de parche deseadas de 3-[4-(butiltio)-1,2,5-tiadiazol-3-il] -1- azabiciclo -[2.2.2]octano.The invention relates to the provision of a method of treating a condition associated with modulation of the muscarinic receptor using a transdermal formulation of 3- [4- (butylthio) -1,2,5-thiadiazol-3-yl] -azabicyclo- [ 2.2.2] octane. The invention provides desired transdermal patch formulations of 3- [4- (butylthio) -1,2,5-thiadiazol-3-yl] -1-azabicyclo - [2.2.2] octane.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP961661 ECSP961661A (en) | 1996-02-01 | 1996-02-01 | TRANSDERMAL FORMULACLION |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP961661 ECSP961661A (en) | 1996-02-01 | 1996-02-01 | TRANSDERMAL FORMULACLION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP961661A true ECSP961661A (en) | 1997-07-28 |
Family
ID=42042395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP961661 ECSP961661A (en) | 1996-02-01 | 1996-02-01 | TRANSDERMAL FORMULACLION |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP961661A (en) |
-
1996
- 1996-02-01 EC ECSP961661 patent/ECSP961661A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KE3243A (en) | Substituted propanolamine and morpholine derivatives | |
| MX9703186A (en) | Indolyl neuropeptide y receptor antagonists. | |
| TR199700799T1 (en) | Transdermal formulation. | |
| AU3054400A (en) | Novel cationic oxidation bases, their use for dyeing keratin fibres, dyeing compositions and dyeing methods | |
| EP1077063A3 (en) | Methods for treating skin pigmentation | |
| BG103556A (en) | 3-pyridyl enantiomers and their application as analgetics | |
| HU9302784D0 (en) | Antiarrhythmic, analgetic effective and through the multi-drug0-resistance(mdr) breaking phth al-azinone derivatives | |
| NO20005668D0 (en) | Compounds with growth hormone releasing properties | |
| AU2734999A (en) | Oxidation dyeing compositions containing a cationic coupling agent, novel cationic coupling agents | |
| DE3275184D1 (en) | 2- (TRISUBSTITUTED PHENYLIMINO) IMIDAZOLINES | |
| DK0874625T3 (en) | Indane derivatives for antipsychotic preparations | |
| DE3269242D1 (en) | Topical compostions for lowering intraocular pressure | |
| PL353875A1 (en) | Substituted pyrrolidin-2,3,4-trion-3-oxime derivatives useful as nmda-receptor antagonists | |
| IT1247974B (en) | PIPERIDINE DERIVATIVES, THEIR PREPARATION AND USE | |
| MY105128A (en) | Bu-3608 derivatives. | |
| BR0005532A (en) | Substituted heterocyclic derivatives | |
| NO954892D0 (en) | Heterocyclic chemistry | |
| NO20002408L (en) | 5-HT1F antagonists | |
| SE9904404L (en) | New composition | |
| ES2171233T3 (en) | USE OF ELIPRODIL FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF ISCHEMICAL DISORDERS OF THE RETINA OR THE OPTICAL NERVE. | |
| ECSP961716A (en) | TRANSDERMICA FORMS | |
| DE68923644D1 (en) | Scissors for shoe lasting machine. | |
| BR9805390B1 (en) | process for preparing 2- (methylsulfonyl) -5-trifluoromethyl) -1,3,4-thiadiazole. | |
| MX9203166A (en) | 1 - [(2-FLUOROFENIL) (4-FLUOROFENIL) FENILMETIL] -IH-IMIDAZOL. | |
| MX9704835A (en) | Heterocyclic n-acetonylbenzamides. |